MARATTO

article · Journal of Planar Chromatography – Modern TLC

A validated and environmentally sustainable high-performance thin-layer chromatography method for the concurrent analysis of axitinib, pazopanib, crizotinib, ruxolitinib, and ibrutinib in bulk drug substances and pharmaceutical formulations

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Chronic Lymphocytic Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Quinazolinone synthesis and applications

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1007/s00764-025-00372-w

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.